Promising Small Cap Stocks To Keep An Eye On – December 12th
by Amy Steele · The Cerbat GemTilray Brands, Spring Valley Acquisition, Direxion Daily TSLA Bear 1X Shares, Destiny Tech100, and Direxion Daily PLTR Bear 1X Shares are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—commonly defined as roughly $300 million to $2 billion, though exact thresholds vary by index provider. Investors view them as offering greater growth potential but also higher volatility, lower liquidity, and typically more company-specific risk compared with mid- or large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Read Our Latest Research Report on TLRY
Spring Valley Acquisition (SV)
Read Our Latest Research Report on SV
Direxion Daily TSLA Bear 1X Shares (TSLS)
The Direxion Daily TSLA Bear 1X Shares (TSLS) is an exchange-traded fund that is based on the Tesla, Inc. index. The fund provides inverse (-1x) exposure, less fees and expenses, to the daily price movement for shares of Tesla stock. TSLS was launched on Aug 9, 2022 and is managed by Direxion.
Read Our Latest Research Report on TSLS
Destiny Tech100 (DXYZ)
Read Our Latest Research Report on DXYZ
Direxion Daily PLTR Bear 1X Shares (PLTD)
Read Our Latest Research Report on PLTD
Further Reading
- MarketBeat’s Top Five Stocks to Own in December 2025
- Chewy Stock Just Flashed a Major Buy Signal for 2026
- Broadcom Slips Post-Earnings Even as AI Demand Goes Parabolic
- Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?
- 2 Small-Cap Biotechs That Could Reward Patient Investors
- Santa Claus May Be Coming Early for Palantir Investors